Cranstoun, Worcestershire’s Drug and Alcohol treatment provider, in collaboration with Manchester Metropolitan University, St Paul’s Hostel and Queen’s University Belfast, are embarking on a pioneering pilot project aimed at developing cutting-edge technology to mitigate the risk of fatal accidental drug overdoses.
The project, focused on wearable overdose detection devices, represents a significant step forward in safeguarding vulnerable individuals and addressing a critical health concern.
The project delivers a wearable device for people who use drugs. It is designed to detect changes in vital signs among individuals at risk of fatal accidental drug overdoses, while they reside in St Pauls. These devices are equipped to send alerts to on-site staff, who will then promptly respond, administer necessary emergency care, including naloxone, and summon emergency services if required. A successful proof of concept was demonstrated by Queens University in Belfast.
Fatal overdoses are increasing year on year, with the UK having some of the highest levels of drug related deaths across Europe. Deaths within supported accommodation facilities, often known as ‘hostels,’ remain a significant concern. These new wearable devices have been designed to intervene and prevent unobserved overdoses from resulting in fatalities.
The pilot project is a collaboration using the technical expertise of Manchester Metropolitan University, the extensive knowledge about drug treatments held by Cranstoun with St Paul’s hostel providing the setting and ongoing support to the at-risk group. Queen’s University Belfast’s role is to provide the project evaluation. Together this project has the potential to save lives and transform the landscape of drug overdose prevention.
